Calyxt Inc (NASDAQ:CLXT) has been given an average rating of “Buy” by the six analysts that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $23.25.
Several equities analysts have recently commented on the stock. ValuEngine upgraded shares of Calyxt from a “hold” rating to a “buy” rating in a research report on Friday, July 20th. Goldman Sachs Group assumed coverage on shares of Calyxt in a research report on Friday, September 7th. They set a “neutral” rating and a $18.00 price target for the company. Finally, Zacks Investment Research upgraded shares of Calyxt from a “hold” rating to a “buy” rating and set a $15.00 price target for the company in a research report on Thursday, October 11th.
Calyxt stock opened at $12.12 on Friday. The stock has a market cap of $395.92 million, a PE ratio of -10.82 and a beta of 3.44. The company has a debt-to-equity ratio of 0.16, a current ratio of 21.27 and a quick ratio of 21.27. Calyxt has a one year low of $11.42 and a one year high of $27.23.
In other news, insider Daniel F. Voytas sold 4,083 shares of the company’s stock in a transaction dated Tuesday, October 9th. The shares were sold at an average price of $13.84, for a total transaction of $56,508.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Manoj Sahoo sold 2,521 shares of the company’s stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $14.84, for a total transaction of $37,411.64. The disclosure for this sale can be found here. Insiders have sold 21,136 shares of company stock valued at $330,964 in the last 90 days. Insiders own 2.80% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC grew its position in Calyxt by 134.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,583 shares of the company’s stock valued at $123,000 after buying an additional 3,781 shares in the last quarter. PNC Financial Services Group Inc. bought a new position in Calyxt in the 2nd quarter valued at about $186,000. California Public Employees Retirement System bought a new position in Calyxt in the 2nd quarter valued at about $187,000. Granite Investment Partners LLC bought a new position in Calyxt in the 2nd quarter valued at about $216,000. Finally, Citadel Advisors LLC bought a new position in Calyxt in the 2nd quarter valued at about $342,000. Hedge funds and other institutional investors own 28.00% of the company’s stock.
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
Read More: What is a Fiduciary?
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.